USE OF FAECAL CALPROTECTIN AS A PROGNOSTIC MARKER OF RESPONSE TO TREATMENT WITH FILGOTINIB: POST HOC ANALYSIS FROM THE SELECTION STUDY

Edouard Louis  ¹     Brian G. Feagan  ²     Tadakazu Hisamatsu  ³     Virginia Taliadouros  ⁴     Rob Jongen  ⁵     Carole Van der Donckt  ⁵     Laurent Peyrin-Biroulet  ^6    
1 CHU Liège University Hospital, Liège, Belgium
² Alimentiv, London, Canada
³ Kyorin University School of Medicine, Tokyo, Japan
⁴ Galapagos NV, Leiden, Netherlands
⁵ Galapagos NV, Mechelen, Belgium
⁶ University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)